Screener
Aurinia Pharmaceuticals AUPH Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
FAQ
- What is Aurinia Pharmaceuticals's inventories?
- Aurinia Pharmaceuticals (AUPH) reported inventories of $45.15M in Q2 2026.
- How has Aurinia Pharmaceuticals's inventories changed year-over-year?
- Aurinia Pharmaceuticals's inventories decreased by 2.9% year-over-year, from $46.5M to $45.15M.
- What is the long-term trend for Aurinia Pharmaceuticals's inventories?
- Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's inventories has grown at a 26.3% compound annual growth rate (CAGR), from $71.93M to $183.18M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Aurinia Pharmaceuticals's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude